CTOs on the Move

Aplicare

www.aplicare.com

 
Founded in 1983 and headquartered in Meriden, CT, Aplicare is a market leader in the formulation, production and packaging of topical antiseptic and personal care products for use in today's professional health care setting. Just recently, we expanded
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

HistoRX

HistoRX is a Branford, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

American Medical supplies and equipment

American Medical supplies and equipment is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

GN ReSound North America

GN ReSound North America is a Glenview, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NeuroOne Incorporated

NeuroOne Medical Technologies Incorporated (Ticker: NMTC) is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, initially targeting epilepsy. Today, our attention is on the development and commercialization of patented thin-film, cortical electrode technology for intracranial electroencephalography (iEEG) and depth electrodes for stereoelectroencephalography (sEEG) recording of brain activity. The products currently available in these categories have significant limitations such as low recording resolution and high risk of infection. NeuroOne believes our technology can address these unmet needs upon initial commercialization with pipeline technology to advance the field by enabling minimally invasive techniques and all-in-one diagnostic and therapeutic options. While our initial focus is Epilepsy, future applications in Parkinson`s disease, Essential tremors, and Dystonia are within sight. NeuroOne technologies will be presented to a well-defined market, eager for the advancement they bring. There are 188 hospital centers licensed to perform epilepsy surgical procedures in the U.S. The current addressable market opportunity for is approximately $525.6 million. As more patients choose the minimally invasive procedures made available by NeuroOne technology, the future opportunity is estimated to be approximately $14.9 billion with full market penetration.

Sonomotion

Sonomotion is a medical device startup that is developing non-invasive solutions for the treatment of kidney stones.